Bairu Menghisteab — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Bairu Menghisteab has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Bairu Menghisteab is listed as a Director of BrainStorm Cell Therapeutics Inc. in SEC filings around May 20, 2026. Publicly available biographical information about Menghisteab is limited; the SEC filing indicates a board-level governance role within BrainStorm. As a director, Menghisteab would participate in oversight of strategy, risk, and corporate governance for the company, subject to the other board members and executive leadership.
Role
Director
Notability
42/100
Board memberships
BrainStorm Cell Therapeutics Inc.
Awards & honors
Serves as a member of BrainStorm Cell Therapeutics Inc. board of directors as of 2026-05-20.
Bairu Menghisteab is listed as a Director of BrainStorm Cell Therapeutics Inc. in SEC filings around May 20, 2026. Publicly available biographical information about Menghisteab is limited; the SEC filing indicates a board-level governance role within BrainStorm. As a director, Menghisteab would participate in oversight of strategy, risk, and corporate governance for the company…
How many SEC Form 4 filings has Bairu Menghisteab submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Bairu Menghisteab's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
